相关实验视频

Updated: Jul 25, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

对于肝细胞癌的免疫检查点抑制剂的进展

Ji Won Han^1,2, Su-Hyung Park³

¹Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul St. Mary's Hospital, Seoul, Korea.

Journal of liver cancer

|June 29, 2023

概括

肝细胞癌 (HCC) 治疗显示免疫疗法具有前景,但大多数患者没有受益. 需要新的策略来提高免疫检查点对肝癌的阻塞疗效.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
肝病学肝病学是一种肝病学.

背景情况:

肝细胞癌 (HCC) 是全球主要的癌症负担,在发病率上排名第五,死亡率第二.
目前的治疗方法,包括免疫检查点抑制剂,提供了新的希望,但在大多数高级HCC患者中显示出有限的疗效.
对于HCC管理中更有效的免疫治疗策略,存在重大未满足的需求.

研究的目的:

对肝细胞癌免疫检查点封锁的最新进展进行审查.
为开发改善的HCC免疫疗法方法提供基础.
突出需要新的策略来增强治疗反应的需要.

主要方法:

对HCC免疫检查点阻塞研究的综合文献综述.
分析当前免疫治疗方法及其局限性.
综合发现,为未来的研究方向提供信息.

主要成果:

免疫检查点抑制剂代表了HCC治疗的重大进展.
很大一部分HCC患者对现有的免疫检查点阻塞疗法没有反应.
目前的免疫疗法在大多数患者的疗效是有限的.

结论:

新型免疫治疗策略对于改善HCC治疗结果至关重要.
需要进一步的研究来克服对免疫检查点封锁的抵抗力.
免疫治疗的合理设计对于推进HCC护理至关重要.

关键词:

肝细胞癌是肝细胞癌.免疫检查点抑制剂免疫检查点抑制剂免疫治疗是一种免疫疗法.在PD-1-PD-L1封锁中.

更多相关视频

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...